Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Technology Digest Yemen.
Press releases published on July 2, 2025
Half of Nord Security’s colocated servers use renewable energy: The company is striving for more
GlobeNewswire
·
July 2, 2025
LONDON, July 02, 2025 (GLOBE NEWSWIRE) -- Nord Security, home to NordVPN, NordLayer, NordPass, NordLocker, NordStellar and Saily, has published its annual Impact Report, addressing all scopes of greenhouse gas emissions, social initiatives, key …
Cizzle Bio Announces Live Investor Webinar on Transforming Lung Cancer Detection
GlobeNewswire
·
July 2, 2025
San Antonio, TX, July 02, 2025 (GLOBE NEWSWIRE) -- Cizzle Bio today announced a live investor webinar scheduled for July 15, 2025, at 1:30 PM PST that will showcase the company’s patented blood test for early-stage lung cancer detection and the commercial …
Genius Group Increases Bitcoin Treasury 20% to 120 Bitcoin; accelerates purchase plan.
GlobeNewswire
·
July 2, 2025
SINGAPORE, July 02, 2025 (GLOBE NEWSWIRE) -- Genius Group Limited (NYSE American: GNS) (“Genius Group” or the “Company”), a leading AI-powered, Bitcoin-first education group, today announced that on July 1, 2025 it increased its Bitcoin Treasury by 20% to …
GDS Announces the Final Offering Price for its C-REIT Initial Public Offering on the Shanghai Stock Exchange
GlobeNewswire
·
July 2, 2025
SHANGHAI, China, July 02, 2025 (GLOBE NEWSWIRE) -- GDS Holdings Limited (“GDS Holdings”, “GDS” or the “Company”) (NASDAQ: GDS; HKEX: 9698), a leading developer and operator of high-performance data centers in China, today announced that the final offering …
VYNE Therapeutics Provides Program Update on Oral BET inhibitor VYN202
GlobeNewswire
·
July 2, 2025
BRIDGEWATER, N.J., July 02, 2025 (GLOBE NEWSWIRE) -- VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”), a clinical-stage biopharmaceutical company focused on developing differentiated therapies to treat chronic inflammatory and immune- …
BriaCell Highlights Additional Phase 3 Clinical Sites Including Los Angeles Cancer Network and Smilow Cancer Hospital at Yale New Haven
GlobeNewswire
·
July 2, 2025
Together, Los Angeles Cancer Network and Smilow Cancer Hospital at Yale New Haven add 30 satellite locations to enroll patients in BriaCell’s pivotal Phase 3 study BriaCell’s Phase 3 study currently has 58 active clinical sites across 15 states, including …
BSTR Miner Launches SOL Cloud Mining Contracts with Unprecedented Demand
GlobeNewswire
·
July 2, 2025
New York City, NY, July 02, 2025 (GLOBE NEWSWIRE) -- With SOL prices set to see a major breakout, investors are flocking to leading AI cloud mining platform BSTR Miner as demand for its newly launched SOL mining contracts surges. Market analysts are …
Abeona Therapeutics® Closes Sale of Rare Pediatric Disease Priority Review Voucher for $155 Million
GlobeNewswire
·
July 2, 2025
CLEVELAND, July 02, 2025 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced the closing of the sale of its Rare Pediatric Disease Priority Review Voucher (PRV) for gross proceeds of $155 million on June 27, 2025. Including net …
ZenaTech Expands Drone as a Service (DaaS) to California with Offer to Acquire an Engineering and Surveying Firm, Tapping into Precision Agriculture and Viticulture Market
GlobeNewswire
·
July 2, 2025
VANCOUVER, British Columbia, July 02, 2025 (GLOBE NEWSWIRE) -- ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) ("ZenaTech"), a technology company specializing in AI (Artificial Intelligence) drone, Drone as a Service (DaaS), and enterprise SaaS, has …
Invivyd and Leading Researchers Form SPEAR (Spike Protein Elimination and Recovery) Study Group to Assess the Effects of Monoclonal Antibody Therapy for Long COVID and COVID-19 Post-Vaccination Syndrome
GlobeNewswire
·
July 2, 2025
SPEAR Study Group initiated following multiple, independent reports of substantial clinical benefit associated with PEMGARDA® (pemivibart) therapy among people with Long COVID SPEAR Study Group collaborators Drs. Michael Peluso, Amy Proal, and David …
Mozart AI Empowers Music Producers With AI Co-Production
GlobeNewswire
·
July 2, 2025
London, July 02, 2025 (GLOBE NEWSWIRE) -- 85% of music today never gets released. London-based Mozart AI has raised $730K in pre-seed funding to solve this problem with the world's first AI-powered Digital Audio Workstation (DAW) that accelerates music …
Dayforce Empowers Canadian Small and Mid-Sized Businesses with Powerpay by Dayforce
GlobeNewswire
·
July 2, 2025
TORONTO, July 02, 2025 (GLOBE NEWSWIRE) -- Dayforce, Inc. (NYSE: DAY; TSX: DAY), a global human capital management (HCM) leader that makes work life better, today announced the rebranding of its payroll and HR solution for Canadian small and mid-sized …
Dayforce offre aux PME canadiennes les moyens de réussir grâce à Powerpay par Dayforce
GlobeNewswire
·
July 2, 2025
TORONTO, July 02, 2025 (GLOBE NEWSWIRE) -- Dayforce, Inc. (NYSE : DAY; TSX : DAY), un chef de file mondial en gestion du capital humain qui améliore la vie au travail, a annoncé aujourd’hui le repositionnement de marque de sa solution de gestion de la paie …
Water Ways Technologies Enters Strategic Partnership for Exclusive Tomato Hybrid Development for Vertical Farming
GlobeNewswire
·
July 2, 2025
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, July 02, 2025 (GLOBE NEWSWIRE) -- Water Ways Technologies Inc. (TSX-V: WWT) (“Water Ways” or the “Company”), a leading provider of advanced agricultural …
Shattuck Labs Announces Participation in Upcoming Leerink Partners Therapeutics Forum: I&I and Metabolism
GlobeNewswire
·
July 2, 2025
AUSTIN, TX and DURHAM, NC, July 02, 2025 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a biotechnology company pioneering the development of novel therapeutics targeting tumor necrosis factor (TNF) superfamily receptors for the …
Pelthos Therapeutics Completes Merger with Channel Therapeutics and Closes $50.1 Million Private Placement
GlobeNewswire
·
July 2, 2025
The combined company plans to launch ZELSUVMI™ for the treatment of molluscum contagiosum infections in July 2025 Concurrent with the closing of the merger, the combined company closed on a $50.1 million equity private placement Combined company will …
Tonix Pharmaceuticals Announces Peer-Reviewed Publication in Cancer Cell Journal Highlighting Positive Preclinical Data of mTNX-1700 in Gastric Cancer Animal Models
GlobeNewswire
·
July 2, 2025
Combination treatment of mTNX-1700 (mTFF2-MSA fusion protein) with anti-PD1 antibody was associated with increased survival and decreased metastases in animal models of gastric cancer relative to anti-PD1 treatment alone mTNX-1700 treatment was associated …
Crypto Losses Surpass $2.47 Billion in H1 2025, CertiK Report Reveals Alarming Rise in Phishing Attacks
GlobeNewswire
·
July 2, 2025
NEW YORK, July 02, 2025 (GLOBE NEWSWIRE) -- CertiK, the world’s largest Web3 security service provider, released its Web3 security quarterly report, Hack3d, for Q2 and H1 2025, revealing that more than $2.47 billion has been lost to hacks, scams, and …
CertiK, ‘Hack3d’ 보안 보고서 발표: 2025년 상반기 손실액 작년 연간치 넘어…피싱 공격이 주요 원인
GlobeNewswire
·
July 2, 2025
뉴욕, July 02, 2025 (GLOBE NEWSWIRE) -- 글로벌 최대 Web3 보안 기업 CertiK이 최신 ‘Hack3d: 2025년 2분기 및 상반기 Web3 보안 보고서’를 발표했다. 보고서에 따르면 2025년 상반기 발생한 보안 사고로 인한 손실액은 약 25억 달러에 달하며, 이는 이미 작년 한 해 전체 손실액을 넘어선 수치다. 전반적으로 Web3 보안 상황은 여전히 심각하며, 공격 방식 또한 지속적으로 진화하고 있다. 보고서에 따르면, …
Denodo Named a Customers’ Choice in the 2025 Gartner Peer Insights “Voice of the Customer”: Data Integration Tools
GlobeNewswire
·
July 2, 2025
PALO ALTO, Calif., July 02, 2025 (GLOBE NEWSWIRE) -- Denodo, a leader in data management, announced that it has been named a Customers’ Choice in the Gartner Peer Insights “Voice of the Customer”: Data Integration Tools, 25 June 2025 report. As of March …